Join to view full profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Fax+1 650-725-0390
Dr. Morrell is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemResidency, Neurology, 1984 - 1990
Stanford University School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1990 - 2027
NY State Medical License 1998 - 2006
NJ State Medical License 2001 - 2005
PA State Medical License 1986 - 1990
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Epilepsy
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016
- America's Top Doctors Castle Connolly, 2002-2014
Publications & Presentations
PubMed
- Clusters in Thalamic iEEG Spectral Features Reveal Sleep/Wake Differences Over Time.David Burdette, Sanjay Patra, Martha Morrell, Lise Johnson
Journal of Clinical Neurophysiology. 2026-07-01 - Responsive stimulation of the thalamus for idiopathic generalized epilepsy: Results of the randomized controlled NAUTILUS trial through 18 months.Utku Uysal, Patrick Landazuri, David E Burdette, Sanjay Patra, Angela N Crudele
Epilepsia. 2026-06-03 - 1 citationsPostapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy: Three-Year Efficacy and Interim Safety Results.Dawn Eliashiv, Vikram R Rao, Barbara C Jobst, Jerzy P Szaflarski, John D Rolston
Neurology. 2026-05-12
Press Mentions
NeuroPace RNS System Treats First LGS Patient in IDE StudyNovember 30th, 2022- NeuroPace Announces First Patient Implanted in NAUTILUS Pivotal Study for the Treatment of Idiopathic Generalized Epilepsy (IGE)October 11th, 2022
- NeuroPace Announces First Patient Treated in Pivotal Study Evaluating the RNS System in AdolescentsMay 4th, 2022
Grant Support
- Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut SyndromeNEUROPACE, INC.2021–2026
- Bone Health In EpilepsyNational Center For Research Resources2004–2005
- Reproductive Function In Women With Bipolar DisordersNational Center For Research Resources2004
- Reproductive Function In Women With EpilepsyNational Center For Research Resources2000–2002
- Effects Of Antiepileptic Drugs On Bone Turnover And MassNational Center For Research Resources2000–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
